Found: 6
Select item for more details and to access through your institution.
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 166, doi. 10.3390/vaccines12020166
- By:
- Publication type:
- Article
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267372
- By:
- Publication type:
- Article
Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1119820
- By:
- Publication type:
- Article
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.1058081
- By:
- Publication type:
- Article
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.978591
- By:
- Publication type:
- Article
Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso.
- Published in:
- Journal of Tropical Medicine (16879686), 2012, p. 1, doi. 10.1155/2012/109705
- By:
- Publication type:
- Article